Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 75%
filed 2026-08-24
Item 7.01
The disclosure centers on convertible debentures issued to Yorkville with $25.775 million aggregate principal, of which $5.775 million has been converted and $20.0 million remains outstanding. Convertible debentures are inherently dilutive securities that can result in issuance of common stock upon conversion. The filing emphasizes "future conversions of the Convertible Debentures" and "potential issuance of additional shares of common stock," signaling material dilution risk to existing shareholders. While the Item 7.01 designation and "Regulation FD Disclosure" framing suggest informational rather than transactional disclosure, the substance involves a dilutive financing arrangement material to investor assessment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 65%
filed 2026-08-24
Item 1.01
RUM Group Inc. entered into a material definitive agreement involving the issuance of a warrant to purchase up to 50,808,408 shares of Class A common stock at $0.01 per share in connection with a commercial agreement, with the warrant issued in reliance on Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-08-24
Item 8.01
The company disclosed supplemental risk factors related to a Commercial Agreement requiring substantial capital investment in data center development and GPU acquisition, highlighting financing risks, construction and operational risks, and regulatory challenges that could impair the company's ability to perform its contractual obligations.
View raw filing on EDGAR →
6-K
Governance Other
confidence 88%
filed 2026-08-24
EX-99.1
CoinShares PLC held an Extraordinary General Meeting on September 15, 2026, at which shareholders voted on four resolutions: authority to repurchase up to 25% of outstanding shares, authority to hold repurchased shares as treasury shares, adoption of the 2026 Equity Incentive Plan, and authority to grant French tax-qualified free shares. These governance matters materially affect shareholder interests and the company's capital structure.
View raw filing on EDGAR →
6-K
Exec departure
confidence 85%
filed 2026-08-24
Mr. LIU Shihao resigned as an executive director of the Company effective August 22, 2026, though he continues as Chief Financial Officer. The principal disclosed action is a person leaving a director role. While the resignation was not due to disagreement and the CFO role continues, the departure from the board constitutes a material change in executive leadership and board composition that would affect a reasonable investor's assessment of governance and management structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-24
EX-99.1
IceCure announced entry into an exclusive distribution agreement with Scovas Medical for ProSense® cryoablation systems in the Netherlands. This is a material operational/commercial event—a strategic partnership expanding the company's European commercialization footprint in a key market where the THERMAC clinical trial is advancing to Phase III. While not a discrete M&A transaction, the exclusive distribution agreement represents a significant commercial milestone that would affect investor assessment of the company's market access and revenue potential.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-24
Evolution Metals announced preliminary inclusion in the Russell 3000® and Russell 2000® indexes effective September 21, 2026, disclosed under Item 7.01 (Regulation FD Disclosure). While index inclusion is a capital-markets milestone that could broaden institutional investor visibility and liquidity, it is primarily an operational/strategic recognition event rather than a discrete financial, governance, or existential event. The filing emphasizes the company's expansion of rare earth magnet production capacity and commercial certifications, positioning this as a business milestone. Index inclusion itself does not constitute a material financial obligation, executive change, M&A activity, or accounting event, but would materially affect investor perception of the company's market profile and accessibility.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-24
Item 8.01
This Item 8.01 disclosure centers on the Offtake Amendment dated August 21, 2026, which modifies a critical condition precedent to USAR's proposed merger with Serra Verde. The amendment revises U.S. government financial support requirements for the special purpose vehicle that will purchase Serra Verde's rare earth production, and the filing explicitly states this satisfies the "Offtake Condition" under Section 6.1(q) of the Merger Agreement. The disclosure describes the completion of a $1.55 billion capitalization of the counterparty and confirms that USAR expects to close the Serra Verde acquisition "in the coming days" following the August 28, 2026 stockholder vote. This is material M&A activity—the amendment removes a closing condition and advances the merger toward completion.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-24
Item 5.02
David Denker was appointed Chief Operating Officer of Rocky Mountain Chocolate Factory, effective August 14, 2026, approved by the Board on August 18, 2026. Denker was promoted from Vice President of Franchise Development to this senior leadership role with expanded responsibility for manufacturing, franchise operations, and strategic execution. The appointment includes a base salary of $185,000, a bonus target of 50%, and equity grants.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-24
EX-99.2
This is a press release announcing unaudited financial results for the six months ended June 30, 2026. The disclosure includes key financial metrics (net revenue of US$55.1 million, net income of US$46.7 million, earnings per share of US$0.81), balance sheet changes (shareholders' equity swinging from a US$116.1 million deficit to US$95.8 million positive), and material acquisitions (Neurovia AI and QC Capital). The material swing in equity position and significant revenue contribution from the QC Capital acquisition make this disclosure material to investors' assessment of the registrant's financial condition and performance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-24
EX-99.1
The press release announces a significant intellectual property milestone: publication of a U.S. patent application covering a novel MDMA-N-acylethanolamines combination for treating PTSD, anxiety, and eating disorders through SciSparc's subsidiary NeuroThera's ongoing collaboration with Clearmind Medicine. This represents advancement of the joint IP portfolio (now thirteen published patent applications globally) and occurs amid FDA finalization of guidance on psychedelic drug development explicitly including MDMA. While this is a material operational and strategic development for the company's drug development pipeline, it does not fit neatly into the specific event categories (it is neither a discrete M&A transaction, a regulatory approval, nor a material contract announcement in the traditional sense), making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-08-24
Item 8.01
Tenon Medical disclosed that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) following a reverse stock split. The company had previously received a non-compliance notice on February 25, 2026, and has now resolved this delisting risk through the 1-for-35 reverse split effective August 10, 2026. This is a material event because the minimum bid price requirement is a continued listing standard, and failure to maintain compliance directly threatens the company's continued listing on Nasdaq.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-24
EX-99.1
This press release announces the U.S. publication of a patent application covering a novel MDMA-N-acylethanolamines combination for treating PTSD, anxiety, and eating disorders, resulting from Clearmind's collaboration with NeuroThera Labs. The disclosure highlights intellectual property advancement (13 patent applications generated through the collaboration, now 19 patent families total) and notes the FDA's recent finalization of guidance explicitly including MDMA in its psychedelic drug development framework. While this is a material operational and strategic milestone for a clinical-stage biotech—expanding IP portfolio and regulatory clarity—it does not fit the discrete event categories of earnings release, M&A activity, executive changes, or other specific material events. The patent publication and regulatory context represent a significant operational/strategic development that would affect investor assessment of the company's pipeline and competitive position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-24
Item 2.01
The filing discloses completion of a disposition of all assets of the Hashdex Bitcoin ETF (a series of the Trust) on August 24, 2026. The Sponsor liquidated all positions (primarily bitcoin) in an over-the-counter transaction to an unaffiliated third party and distributed cash proceeds to shareholders pro rata. This constitutes a material disposition event under Item 2.01, representing the effective termination and liquidation of the Fund.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-24
Item 5.02
Todd Edwards was appointed as Chief Commercial Officer of Oruka Therapeutics, commencing August 24, 2026, pursuant to a letter agreement dated July 22, 2026. The disclosure details his appointment, compensation package (base salary of $525,000, 40% bonus target, stock options and RSUs), and severance arrangements. This is a material executive appointment of a senior officer with significant commercial responsibility at a biopharmaceutical company.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-08-24
Item 5.03
Longeveron implemented a 1-for-10 reverse stock split, approved by stockholders on July 1, 2026 and effective August 26, 2026, to regain compliance with Nasdaq Capital Market's $1.00 minimum bid price requirement for continued listing. The amendment to the Certificate of Incorporation was filed August 20, 2026, reducing outstanding shares from approximately 30.4 million to 3.0 million.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-24
Item 3.01
Senmiao Technology received a Nasdaq notification on August 21, 2026, that it failed to maintain the minimum $2,500,000 stockholders' equity required under Listing Rule 5550(b)(1), with reported stockholders' equity of negative $35,344,336 as of June 30, 2026. The company has 45 days to submit a compliance plan or face potential delisting. This is a direct notice of failure to satisfy a continued listing standard, the core definition of delisting_risk.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-08-24
The 6-K discloses the results of a Class A Meeting and Extraordinary General Meeting held on August 18, 2026, where shareholders voted on proposals to increase Class B voting rights from 20 to 200 votes per share and adopt amended articles of association. Although the Class B shareholders subsequently withdrew their consent on August 24, 2026 (preventing implementation), the filing reports the shareholder vote results as required under Item 5.07. The voting outcomes and subsequent withdrawal are material governance events affecting the company's capital structure and shareholder rights.
View raw filing on EDGAR →
6-K
Going Concern
confidence 92%
filed 2026-08-24
The 6-K discloses that Gauzy Ltd. has proposed a debt settlement under Israeli insolvency law (Section 10 of the Insolvency and Economic Rehabilitation Law, 5778-2018) "in order to avoid the commencement of insolvency proceedings against the Company." Creditors' meetings are scheduled for August 27, 2026, with a Court hearing on September 6, 2026, to approve the settlement. This disclosure of a formal debt-restructuring process initiated to prevent insolvency proceedings is a material signal of substantial doubt about the registrant's ability to continue as a going concern.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 72%
filed 2026-08-24
Item 1.01
Air Industries Group entered into a Twelfth Amendment to its Loan and Security Agreement with Webster Bank, extending the maturity date of revolving credit and term loans to November 30, 2026, and concurrently extended subordinated notes held by Michael and Robert Taglich to December 1, 2026. While this is technically an amendment to existing debt rather than a new issuance, it represents a material modification of direct financial obligations and is disclosed under Item 1.01 (Entry Into a Definitive Material Agreement), indicating the company views it as a material event. The repeated amendments (twelfth amendment) and near-term maturity dates suggest potential refinancing pressure, making this material to investors assessing the company's liquidity and financial stability.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-24
The 6-K discloses results of an Extraordinary General Meeting held on August 21, 2026, where shareholders voted on four proposals: (1) increase in authorized ordinary shares from 70 million to 1 billion; (2) an 8-for-1 reverse stock split; (3) approval for a share consolidation at a ratio between 1-for-2 and 1-for-50; and (4) amendments to the memorandum and articles of association. All four proposals passed with approximately 99.99% approval. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the reverse split and share consolidation are material capital structure changes that would affect a reasonable investor's assessment.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-24
The 6-K discloses a private placement of 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share, closed on August 18, 2026, generating approximately $2.125 million in gross proceeds. The securities were issued in reliance on Section 4(a)(2) of the Securities Act and Regulation S, with no general solicitation. This is a classic unregistered equity issuance that dilutes existing shareholders and materially affects the capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-24
StablecoinX entered into Note Consolidation and Restructuring Agreements on August 21, 2026, converting approximately $6.9 million in convertible promissory notes into warrants (Tranche A and Tranche B) exercisable for Class A common stock. Item 3.02 explicitly discloses the unregistered issuance of these warrants in reliance on Section 4(a)(2) of the Securities Act. The conversion of debt into equity warrants represents a dilutive issuance material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-24
Item 3.01
Nasdaq notified the Company on August 21, 2026, that its market value of listed securities (MVLS) fell below the $50 million minimum requirement under Nasdaq Listing Rule 5450(b)(2)(A). The Company has 180 calendar days until February 17, 2027, to regain compliance; failure to do so will trigger delisting proceedings. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-08-24
The 6-K discloses three putative securities class actions filed against Linkers Industries in New York state court alleging violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 related to alleged market manipulation in IPO offerings. The Company has been served in at least one action (Morales Action) and intends to defend vigorously. This is material litigation that would affect a reasonable investor's assessment of legal and financial risk.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-24
The 6-K discloses a board resolution calling an extraordinary general meeting (EGM) on September 9, 2026, to seek shareholder approval for three proposals: (1) adoption of a fourth amended and restated memorandum and articles of association, (2) authorization for directors to implement ancillary matters, and (3) authorization for the meeting chairman to adjourn if necessary. The primary substance is amendment of the company's governing documents, including changes to written resolution procedures, dispute resolution jurisdiction, and authorized share capital—all governance matters. While not a specific named type (exec appointment, compensation, shareholder vote results, etc.), this is clearly a governance event material to shareholders' understanding of corporate structure and voting procedures.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-08-24
The Company suspended and is terminating its at-the-market (ATM) sales agreement with Chaince Securities, LLC under which it had sold 25,606,595 Ordinary Shares for approximately $2.3 million in gross proceeds since July 2026. While the termination itself is administrative, the disclosure documents the completion of a dilutive equity issuance under an ATM offering program, which materially affects shareholder equity and voting power. The suspension and termination of the agreement is the operative event being disclosed.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-08-24
Item 1.01
Change Agents Corporation amended its Equity Purchase Agreement with Hudson Global Ventures, LLC on August 21, 2026, establishing a $10,000,000 equity line of credit whereby the Company can require the Investor to purchase common stock at $0.20 per share, subject to an Exchange Cap limiting issuances to 19.99% of outstanding shares pending stockholder approval. This unregistered equity issuance is material and dilutive to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-24
Item 1.01
Greenland Mines entered into an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners on August 24, 2026, authorizing the sale of up to $50,000,000 in common stock shares. This is a classic dilutive equity issuance under Rule 415(a)(4), where the company may sell registered shares at market prices through a sales agent. The filing explicitly describes this as an "ATM Offering" and notes the company has no obligation to sell but may do so from time to time, making this a material capital-raising activity that would dilute existing shareholders.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-24
EX-99.3
This is a press release announcing first-half 2026 financial results for Wearable Devices Ltd., dated August 24, 2026. The exhibit discloses six-month revenues of $350 thousand (vs. $294 thousand in H1 2025), net loss of $5.5 million (vs. $3.7 million in H1 2025), and includes interim condensed consolidated financial statements (balance sheet, comprehensive loss statement, and cash flow statement). The disclosure is material as it reports interim financial performance and operational updates that would affect a reasonable investor's assessment of the company's financial condition and progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-24
Item 1.01
The Company entered into two registered direct offerings on August 18 and August 20, 2026, selling 340,000 shares and 451,250 shares of common stock respectively, plus pre-funded warrants to purchase 260,000 and 1,111,250 additional shares, for aggregate gross proceeds of approximately $6.8 million. This is a material dilutive equity issuance that raises capital through the sale of common stock and immediately-exercisable warrants, typical of a PIPE-like registered direct offering structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-24
Item 2.02
La Rosa Holdings Corp. issued a press release on August 24, 2026, announcing financial results for the second quarter and first half of 2026, including revenue of $28.6 million, gross profit of $3.7 million, and net loss of $15.6 million, with detailed financial statements and management commentary on operating performance.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-24
Item 3.01
La Rosa received a notice from Nasdaq on August 21, 2026, that it failed to comply with Nasdaq Listing Rule 5250(c)(1) due to delinquent filing of its Form 10-Q. Although the company subsequently filed the Form 10-Q on August 21 and regained compliance by August 24, the notice documented the initial non-compliance and potential delisting risk, with Nasdaq retaining discretion to grant up to 180 days to regain compliance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-24
Item 5.07
Annual Meeting of Stockholders held on August 21, 2026, resulted in election of five directors (Gene S. Bertcher, Richard W. Humphrey, Dan Locklear, Cecelia Maynard, and Robert C. Canham II), ratification of Turner Stone & Company LLP as independent auditor, and approval of issuance of 2,000,000 new shares of Common Stock to Realty Advisors, Inc. for $2,000,000.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-24
Item 5.01
Issuance of 2,000,000 shares of Common Stock to Realty Advisors, Inc. at $1.00 per share pursuant to a Subscription Agreement dated April 13, 2026, will increase RAI's ownership from 7.79% to approximately 33.65% of outstanding shares, constituting a material change in control of the Company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-24
Item 5.02
Erik Strandberg, Chief Commercial Officer, is departing EBR Systems in the coming months. The CEO will assume his responsibilities during the search for a successor.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-24
EX-99.1
This news release discloses Aurora Cannabis's response to Curaleaf Holdings' unsolicited take-over bid (hostile bid), which constitutes a material acquisition or change-of-control event. The release explicitly states that "Aurora's Board of Directors, together with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal" and advises shareholders to "TAKE NO ACTION" pending formal recommendation. The offer remains open for at least 105 days, making this an active M&A transaction that would materially affect the registrant's future and shareholder value.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-24
EX-99.1
IsoEnergy has entered into an Exploration Agreement with Kineepik Métis Local Inc. to establish a framework for engagement, information sharing, and collaboration as the company advances uranium exploration in Saskatchewan. This is a material operational and strategic partnership that provides community members with employment, training, and business opportunities. While not a discrete M&A transaction, debt issuance, or other named event type, the agreement represents a significant operational milestone for the company's exploration activities and community relations in a key jurisdiction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-24
Item 5.02
W. Noah Springer was appointed as Chief Executive Officer effective January 1, 2027, following a board-approved succession plan, and was elected to the board of directors. This appointment represents a significant leadership transition at the major REIT.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-24
EX-99.1
Afya discloses that discussions with Yduqs Participações S.A. regarding a "potential business combination" are underway at an early stage, following Yduqs's material fact disclosure under Brazilian law. Although no binding agreement has been entered into, the announcement of active discussions about a material acquisition or merger constitutes a material event that would affect a reasonable investor's assessment of the registrant's strategic direction and value.
View raw filing on EDGAR →
6-K
Bankruptcy Filing
confidence 95%
filed 2026-08-24
Braskem's Board approved filing a petition for "extrajudicial reorganization" (reorganização extrajudicial) pursuant to Brazilian Law 11,101/05, which is Brazil's bankruptcy and insolvency law. The filing covers approximately US$10.9 billion in unsecured financial obligations. Although styled as "extrajudicial," this is a formal insolvency proceeding under Brazilian law equivalent to Chapter 11 reorganization, representing a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →
6-K
Bankruptcy Filing
confidence 95%
filed 2026-08-24
Braskem S.A. filed a petition for extrajudicial reorganization (recuperação judicial) under Brazilian Law 11,101/05 with the 2nd Bankruptcy and Judicial Reorganization Court of São Paulo on August 24, 2026, covering unsecured financial obligations of approximately US$10.9 billion. This is a formal bankruptcy/reorganization proceeding that suspends enforceability of the Subject Claims and represents a terminal restructuring event materially threatening the registrant's continued existence in its current form.
View raw filing on EDGAR →
6-K
Terminal Other
confidence 85%
filed 2026-08-24
Braskem has filed a request for "out-of-court reorganization" (Extrajudicial Reorganization) and is negotiating with holders of Senior Notes and Debentures regarding a reorganization plan. This is a material event threatening the registrant's continued existence or financial structure that does not fit the specific bankruptcy_filing category (which typically refers to formal court filings under Chapter 11 or analogous proceedings), but clearly signals severe financial distress and a restructuring of the company's capital structure and obligations.
View raw filing on EDGAR →
6-K
Terminal Other
confidence 95%
filed 2026-08-24
The Board of Directors approved filing an Out-of-Court Restructuring Proceeding (Recuperação Extrajudicial) in Brazil and a Chapter 15 proceeding in the United States for Braskem and five subsidiaries. This is a material restructuring event that materially threatens the registrant's continued existence and does not fit a specific terminal category (not a bankruptcy filing per se, but a formal restructuring proceeding). The resolution explicitly authorizes protective measures and implementation of a restructuring plan, signaling substantial financial distress.
View raw filing on EDGAR →
6-K
Terminal Other
confidence 95%
filed 2026-08-24
Braskem SA has filed a petition for extrajudicial recovery (recuperação extrajudicial) under Brazilian insolvency law (Lei nº 11.101/05), seeking to restructure approximately R$187 billion in financial debt across six group entities. The filing demonstrates a material financial distress event threatening the registrant's continued existence: the company initiated mediation with major creditors on June 24, 2026, obtained a preliminary stay order on June 26, 2026, and now seeks formal extrajudicial recovery with creditor consent (39.6% of subject credits already signed). This is a terminal event—an existential threat requiring judicial restructuring—that does not fit the specific bankruptcy_filing category (which contemplates Chapter 11 or analogous formal insolvency proceedings) but clearly signals severe financial distress and restructuring necessity.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-24
EX-99.1
This exhibit announces a webcast to discuss "operational highlights and financial results for the full year ended June 30, 2026." The disclosure explicitly references financial results for a complete fiscal year and invites investors to a webcast presentation on those results, which is the hallmark of an earnings release announcement. While the actual detailed financial figures are not included in this exhibit itself, the announcement of the results presentation and the company's operational updates constitute an earnings release event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-24
EX-99.1
ZenaTech completed its acquisition of Benchmark Partners LLC (Galena-Benchmark Engineering), a civil engineering and land surveying firm in Ketchum, Idaho. This is the company's 27th Drone as a Service acquisition and represents entry into Idaho, the 13th U.S. state in its geographic footprint.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-24
EX-99.5
ZenaTech completed its acquisition of Cogswell Engineering, Ltd., a Canadian-based civil and structural engineering firm. This is the company's 28th Drone as a Service acquisition and its third acquisition in Canada, further expanding the DaaS platform and geographic footprint.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-24
EX-99.2
ZenaDrone commenced in-house PCB flight testing as part of a vertical integration strategy to advance toward NDAA-compliant Blue UAS certification and capture U.S. defense market opportunities. The initiative emphasizes supply-chain resilience and margin improvement while positioning the company for defense contracts.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-24
EX-99.3
ZenaTech expanded its ZenaWorx software to include digital terrain modeling (DTM) capabilities and signed its first paying customer in the AI data center construction market. The expansion represents a new recurring revenue opportunity in the global digital elevation model market.
View raw filing on EDGAR →